Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01446471 · ClinicalTrials.gov registry record
REASON 1 Trial: Sonography in Cardiac Arrest
A clinical trial of Cardiac Arrest and Pulseless Electrical Activity, sponsored by University of Massachusetts, Worcester.
- Completed
- Registry status
- 793
- Enrollment target
- 7
- Study locations
NCT01446471: Completed study of Cardiac Arrest and Pulseless Electrical Activity, sponsored by University of Massachusetts, Worcester.
NCT01446471 is a study of Cardiac Arrest and Pulseless Electrical Activity that has completed, run by University of Massachusetts, Worcester. The registered enrollment target is 793 participants, below the 1,454-participant average among 31 other Cardiac Arrest trials with a reported enrollment target (45% lower). The trial reports 7 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01446471, a study of Cardiac Arrest and Pulseless Electrical Activity, has completed, sponsored by University of Massachusetts, Worcester.
- COMPLETED
- Registry status
- 793 participants
- Enrollment target
- 7
- Study locations
Study Summary
The aim of this study is to investigate the predictive value of the presence or absence of cardiac activity by bedside ultrasound during cardiac arrest. The investigators anticipate based on previous research that patients who suffer a cardiac arrest and have cardiac activity on bedside ultrasound will have a greater chance of surviving to hospital admission. The investigators hypothesis is that the mortality rate in patients in cardiac arrest with no cardiac activity by ultrasound will have a mortality rate of 100%.
Primary Outcome
Participants will be followed for the duration of hospital stay, an expected average of up to 12 months. The time frame is an estimate based on previous research. Patients could survive hours to days to weeks or months.
Conditions Studied
Study Locations (7)
Massachusetts
- Massachusetts General Hospital - Boston
- UMASS Memorial Medical Center - Worcester
Delaware
- Christiana Health Care - Newark
Missouri
- Washington University Hospital - St Louis
New York
- Northshore University Hospital - Manhasset
North Carolina
- Carolinas Medical Center - Charlotte
Other
- University of Ottowa - Ottowa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 793 participants |
| Start Date | 2010-01 |
| Est. Completion | 2015-11 |
What the finished NCT01446471 record still lists
NCT01446471 is an observational study that tracks outcomes without assigning an intervention. The registered 793 participants enrollment target is mid-sized for trials with a published cap, below the 1,454-participant average among 31 other Cardiac Arrest trials with a reported enrollment target (45% lower).
The record links to 3 conditions, with Cardiac Arrest appearing as the primary indexed condition, and to 0 interventions.
NCT01446471 lists 7 locations in 6 states (Massachusetts, Delaware, Missouri).
Frequently Asked Questions
What is clinical trial NCT01446471 about?
NCT01446471 is a clinical study titled "REASON 1 Trial: Sonography in Cardiac Arrest". The aim of this study is to investigate the predictive value of the presence or absence of cardiac activity by bedside ultrasound during cardiac arrest. The investigators anticipate based on previous research that patients who suffer a cardiac arrest and have cardiac activity on bedside ultrasound w...
What is the current status of trial NCT01446471?
This trial is currently completed. The enrollment target is 793 participants. The study started on 2010-01. Estimated completion is 2015-11.
What conditions does trial NCT01446471 study?
This clinical trial studies the following conditions: Cardiac Arrest, Pulseless Electrical Activity, Asystole.
Who is sponsoring clinical trial NCT01446471?
This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01446471 being conducted?
This trial has 7 study locations across Delaware, Massachusetts, Missouri, New York, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiac Arrest
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01446471's enrollment target sits among peer trials
793 8th of 31 higher than 24 of 31 other Cardiac Arrest trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cardiac Arrest trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Early Amiodarone in Shockable Cardiac Arrest
RECRUITING · Phase 3
-
Hospital Airway Resuscitation Trial
RECRUITING · NA
-
Post-CA Neuroprotection With Magnesium
RECRUITING · Phase 1
-
Impact of Aerosol Box Use During Cardiopulmonary Arrest: A Multicenter Study
RECRUITING · NA
-
Resuscitative TEE Collaborative Registry
RECRUITING
-
Hydrogen's Feasibility and Safety as a Therapy in ECPR
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03424005 · 792 participants · Phase 1
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer
- NCT05866081 · 792 participants · NA
Stent Omission After Ureteroscopy and Lithotripsy in the Michigan Urological Surgery Improvement Collaborative
- NCT06722352 · 792 participants · NA
Palliative Care Education in Assisted Living for Dementia Care Providers (PCEAL-DCP)
- NCT06208150 · 795 participants · Phase 3
A Study Comparing Talquetamab Plus Pomalidomide, Talquetamab Plus Teclistamab, and Elotuzumab, Pomalidomide, and Dexamethasone or Pomalidomide, Bortezomib, and Dexamethasone in Participants With Relapsed or Refractory Myeloma Who Have Received an Anti-CD38 Antibody and Lenalidomide
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia